Skip to main content
. 2020 Jul 6;146(12):3323–3332. doi: 10.1007/s00432-020-03310-x

Table 3.

Characteristics of patients with lung cancer or second lung cancers after PSM analysis

Lung cancer Second lung cancer p value
n = 165 (%) n = 166 (%)
Gender
 Male 19 (11.5) 47 (28.3) < 0.001
 Female 146 (88.5) 119 (71.7)
Operation
 Anatomic resection 108 (65.5) 95 (57.2) 0.143
 Sublobar resection 57 (34.5) 71 (42.8)
Differentiation
 Good 88 (53.3) 77 (46.4) 0.362
 Moderate 60 (36.4) 73 (44.0)
 Poor 17 (10.3) 16 (9.6)
EGFR gene status
 Wild-type 39 (23.6) 48 (28.9) 0.253
 Mutation 54 (43.6) 60 (36.1)
 Non-test 72 (32.7) 58 (34.9)
N Status
 N0 149 (90.3) 150 (90.4) 0.558
 N1 5 (3.0) 8 (4.8)
 N2 11 (6.7) 8 (4.8)
Histological type
 Adenocarcinoma 152 (92.1) 152 (91.6) 0.628
 Squamous cell carcinoma (SCC) 6 (3.6) 9 (5.4)
 Others 7 (4.2) 5 (3.0)
Performance status (PS)
 0 92 (55.8) 107 (64.5) 0.219
 1 56 (33.9) 50 (30.1)
 2 16 (9.7) 9 (5.4)
 3 1 (0.6) 0 (0)
Location
 Central 72 (43.6) 87 (52.4) 0.124
 Peripheral 93 (56.4) 79 (47.6)
Adjuvant chemotherapy
 Yes 52 (31.5) 45 (27.1) 0.400
 No 113 (68.5) 121 (72.9)
Adjuvant radiotherapy
 Yes 12 (7.3) 10 (6.0) 0.666
 No 153 (92.7) 156 (94.0)
Smoking
 Yes 22 (13.3) 24 (14.5) 0.166
 No 139 (84.2) 131 (78.9)
 Ex-smoker 4 (2.4) 11 (6.6)
Lymphovascular space invasion (LVSI)
 Absent 152 (92.1) 154 (93.3) 0.833
 Present 13 (7.9) 11 (6.7)
Visceral pleural invasion (VPI)
 Absent 163 (98.8) 158 (95.8) 0.174
 Present 2 (1.2) 7 (4.2)
Stage
 0 2 (1.2) 7 (4.2) 0.283
 I 139 (84.2) 135 (81.3)
 II 5 (3.0) 9 (5.4)
 III 16 (9.7) 11 (6.6)
 IV 3 (1.8) 4 (2.4)

Statistical significance is defined as p < 0.05 (Bold)